Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)
Camille Verry, Jacques Balosso, G. Truc(Centre Georges François Leclerc), Nicolas Milhade, M. Loo, Fabien Boux, Antoine Leboucher(Inserm), Sandrine Dufort, Joby Jacob(Dr. Balasaheb Sawant Konkan Krishi Vidyapeeth), Paul Lesueur, Olivier Beaumont(Stallergenes Greer (France)), Gerardo Villa, G. Le Duc, C. Chira(Institut universitaire du cancer de Toulouse Oncopole), G. Noël(Hôpital Pierre Wertheimer), P. Giraud(Inserm), Ambra Stefani(Innsbruck Medical University), A. D'hombre, Matthieu Roustit, M. Gataleta, Antoine Vilotitch
International Journal of Radiation Oncology*Biology*Physics
September 1, 2025
Cited by 2
Related Papers
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Biopolymer based nanomaterials in drug delivery systems: A review
|Materials Today Chemistry|2018|573
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis
|Journal of Allergy and Clinical Immunology|2007|485
Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
|Nature Communications|2018|406